Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trialMiriam Santer, Alison Layton, Sarah Pyne et al.|BMJ|2023Cited by 60
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCTMiriam Santer, Alison Layton, Megan Lawrence et al.|Health Technology Assessment|2024Cited by 7
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trialSarah Pyne, Miriam Santer, Tracey Sach et al.|BMJ Open|2023Cited by 5